# XPHOZAH
> **NDA213931** · New Drug Application · Sponsor: ARDELYX INC · Approved 2023-10-17
## Drug
- **FDA Application Number:** NDA213931
- **Application type:** New Drug Application
- **Brand name:** XPHOZAH
- **Generic name:** TENAPANOR
- **Active ingredients:** TENAPANOR HYDROCHLORIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ARDELYX INC
- **Manufacturer:** Ardelyx, Inc.
- **First approval:** 2023-10-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213931)
---
*AI Analytics · CC0 1.0*